Acylated but not des-acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease

Journal of Neurochemistry

Volumn 137, Issue 3, 2016, Pages 460-471

  Bayliss, Jacqueline A ^a   Lemus, Moyra ^a   Santos, Vanessa V ^a   Deo, Minh ^a   Elsworth, John D ^b   Andrews, Zane B ^a  

^a MONASH UNIVERSITY   (Australia)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acylated ghrelin; corticosterone; des acylated ghrelin; dopamine; GOAT; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACYLATED GHRELIN; ACYLTRANSFERASE; CELL PROTEIN; DES ACYL GHRELIN; GHRELIN; GHRELIN O ACYLTRANSFERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; AIF1 PROTEIN, MOUSE; CALCIUM BINDING PROTEIN; GHRELIN O-ACYLTRANSFERASE, MOUSE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; NEUROPROTECTIVE AGENT;

ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL VOLUME; CONTROLLED STUDY; DEACETYLATION; DOPAMINERGIC NERVE CELL; DRUG TARGETING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE METABOLISM; KNOCKOUT MOUSE; MALE; MICROGLIA; MOUSE; MOUSE MODEL; MPTP-INDUCED PARKINSONISM; NERVE CELL NECROSIS; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHEMISTRY; GENETICS; METABOLISM; MPTP POISONING; NERVE CELL; NERVE TRACT; PARKINSON DISEASE, SECONDARY; PATHOLOGY;

ACYLATION; ACYLTRANSFERASES; ANIMALS; CALCIUM-BINDING PROTEINS; CELL COUNT; GHRELIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROFILAMENT PROTEINS; MPTP POISONING; NEURAL PATHWAYS; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE, SECONDARY; TYROSINE 3-MONOOXYGENASE;

EID: 84963776678     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13576     Document Type: Article

References (53)

1. Ahmad A., Rasheed N., Banu N., and, Palit G., (2010) Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 13, 355-364.
2. Akamizu T., Shinomiya T., Irako T., Fukunaga M., Nakai Y., Nakai Y., and, Kangawa K., (2005) Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J. Clin. Endocrinol. Metab. 90, 6-9.
3. Andrews Z. B., Erion D., Beiler R., et al,. (2009) Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J. Neurosci. 29, 14057-14065.
4. Asakawa A., Inui A., Kaga T., et al,. (2001) A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 74, 143-147.
5. Aviles-Olmos I., Dickson J., Kefalopoulou Z., et al,. (2013) Exenatide and the treatment of patients with Parkinson's disease. J. Clin. Investig. 123, 2730-2736.
6. Bertilsson G., Patrone C., Zachrisson O., et al,. (2008) Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease. J. Neurosci. Res. 86, 326-338.
7. Beynon A. L., Brown M. R., Wright R., Rees M. I., Sheldon I. M., and, Davies J. S., (2013) Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones. J. Neuroinflammation 10, 40.
8. Briggs D. I., Lockie S. H., Wu Q., Lemus M. B., Stark R., and, Andrews Z. B., (2013) Calorie-restricted weight loss reverses high-fat diet-induced ghrelin resistance, which contributes to rebound weight gain in a ghrelin-dependent manner. Endocrinology 154, 709-717.
9. Bulgarelli I., Tamiazzo L., Bresciani E., Rapetti D., Caporali S., Lattuada D., Locatelli V., and, Torsello A., (2009) Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils. J. Neurosci. Res. 87, 2718-2727.
10. Chen H., Zhang S. M., Hernan M. A., Schwarzschild M. A., Willett W. C., Colditz G. A., Speizer F. E., and, Ascherio A., (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch. Neurol. 60, 1059-1064.
11. Chung H., Seo S., Moon M., and, Park S., (2008) Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J. Endocrinol. 198, 511-521.
12. Cummings D. E., Purnell J. Q., Frayo R. S., Schmidova K., Wisse B. E., and, Weigle D. S., (2001) A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714-1719.
13. Deuschle M., Weber B., Colla M., Depner M., and, Heuser I., (1998) Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: a re-evaluation study. Stress 2, 281-287.
14. Dhurandhar E. J., Allison D. B., van Groen T., and, Kadish I., (2013) Hunger in the absence of caloric restriction improves cognition and attenuates Alzheimer's disease pathology in a mouse model. PLoS ONE 8, e60437.
15. Diano S., Farr S. A., Benoit S. C., et al,. (2006) Ghrelin controls hippocampal spine synapse density and memory performance. Nat. Neurosci. 9, 381-388.
16. Dixit V. D., Schaffer E. M., Pyle R. S., Collins G. D., Sakthivel S. K., Palaniappan R., Lillard J. W., Jr, and, Taub D. D., (2004) Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Investig. 114, 57-66.
17. Epelbaum J., Bedjaoui N., Dardennes R., et al,. (2010) Role of the ghrelin/obestatin balance in the regulation of neuroendocrine circuits controlling body composition and energy homeostasis. Mol. Cell. Endocrinol. 314, 244-247.
18. Gonzalez-Rey E., Chorny A., and, Delgado M., (2006) Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130, 1707-1720.
19. Hartmann A., Veldhuis J. D., Deuschle M., Standhardt H., and, Heuser I., (1997) Twenty-four hour cortisol release profiles in patients with Alzheimer's and Parkinson's disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging 18, 285-289.
20. Hwang S., Moon M., Kim S., Hwang L., Ahn K. J., and, Park S., (2009) Neuroprotective effect of ghrelin is associated with decreased expression of prostate apoptosis response-4. Endocr. J. 56, 609-617.
21. Ikawa M., Okazawa H., Kudo T., Kuriyama M., Fujibayashi Y., and, Yoneda M., (2011) Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET. Nucl. Med. Biol. 38, 945-951.
22. Jiang H., Li L. J., Wang J., and, Xie J. X., (2008) Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp. Neurol. 212, 532-537.
23. Kim S. T., Choi J. H., Chang J. W., Kim S. W., and, Hwang O., (2005) Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J. Neurochem. 95, 89-98.
24. Kohutnicka M., Lewandowska E., Kurkowska-Jastrzebska I., Czlonkowski A., and, Czlonkowska A., (1998) Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology 39, 167-180.
25. Ku J. M., Andrews Z. B., Barsby T., et al,. (2015) Ghrelin-related peptides exert protective effects in the cerebral circulation of male mice through a nonclassical ghrelin receptor(s). Endocrinology 156, 280-290.
26. Li W. G., Gavrila D., Liu X., et al,. (2004) Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109, 2221-2226.
27. Li L., Zhang L. K., Pang Y. Z., Pan C. S., Qi Y. F., Chen L., Wang X., Tang C. S., and, Zhang J., (2006) Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol. Sin. 27, 527-535.
28. Li Y., Perry T., Kindy M. S., et al,. (2009) GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc. Natl Acad. Sci. USA 106, 1285-1290.
29. Liu Y., Chen L., Xu X., Vicaut E., and, Sercombe R., (2009) Both ischemic preconditioning and ghrelin administration protect hippocampus from ischemia/reperfusion and upregulate uncoupling protein-2. BMC Physiol. 9, 17.
30. Lucchi C., Curia G., Vinet J., Gualtieri F., Bresciani E., Locatelli V., Torsello A., and, Biagini G., (2013) Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus. PLoS ONE 8, e72716.
31. Lupien S. J., de Leon M., de Santi S., et al,. (1998) Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1, 69-73.
32. Malisch J. L., Breuner C. W., Gomes F. R., Chappell M. A., and, Garland T., Jr, (2008) Circadian pattern of total and free corticosterone concentrations, corticosteroid-binding globulin, and physical activity in mice selectively bred for high voluntary wheel-running behavior. Gen. Comp. Endocrinol. 156, 210-217.
33. Mani B. K., Walker A. K., Lopez Soto E. J., Raingo J., Lee C. E., Perello M., Andrews Z. B., and, Zigman J. M., (2014) Neuroanatomical characterization of a growth hormone secretagogue receptor-green fluorescent protein reporter mouse. J. Comp. Neurol. 522, 3644-3666.
34. Metz G. A., Jadavji N. M., and, Smith L. K., (2005) Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior. Eur. J. Neurosci. 22, 1190-1200.
35. Meyer R. M., Burgos-Robles A., Liu E., Correia S. S., and, Goosens K. A., (2014) A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol. Psychiatry 19, 1284-1294.
36. Moon M., Kim H. G., Hwang L., et al,. (2009) Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox. Res. 15, 332-347.
37. Ouchi Y., Yoshikawa E., Sekine Y., Futatsubashi M., Kanno T., Ogusu T., and, Torizuka T., (2005) Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann. Neurol. 57, 168-175.
38. Patterson M., Murphy K. G., le Roux C. W., Ghatei M. A., and, Bloom S. R., (2005) Characterization of ghrelin-like immunoreactivity in human plasma. J. Clin. Endocrinol. Metab. 90, 2205-2211.
39. Portelli J., Coppens J., Demuyser T., and, Smolders I., (2015) Des-acyl ghrelin attenuates pilocarpine-induced limbic seizures via the ghrelin receptor and not the orexin pathway. Neuropeptides 51, 1-7.
40. Sakata I., Yang J., Lee C. E., Osborne-Lawrence S., Rovinsky S. A., Elmquist J. K., and, Zigman J. M., (2009) Colocalization of ghrelin O-acyltransferase and ghrelin in gastric mucosal cells. Am. J. Physiol. Endocrinol. Metab. 297, E134-E141.
41. Satou M., Nishi Y., Yoh J., Hattori Y., and, Sugimoto H., (2010) Identification and characterization of acyl-protein thioesterase 1/lysophospholipase I as a ghrelin deacylation/lysophospholipid hydrolyzing enzyme in fetal bovine serum and conditioned medium. Endocrinology 151, 4765-4775.
42. Spencer S. J., Xu L., Clarke M. A., Lemus M., Reichenbach A., Geenen B., Kozicz T., and, Andrews Z. B., (2012) Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol. Psychiatry 72, 457-465.
43. Takagi K., Legrand R., Asakawa A., et al,. (2013) Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat. Commun. 4, 2685.
44. Theil M. M., Miyake S., Mizuno M., et al,. (2009) Suppression of experimental autoimmune encephalomyelitis by ghrelin. J. Immunol. 183, 2859-2866.
45. Tong J., Dave N., Mugundu G. M., Davis H. W., Gaylinn B. D., Thorner M. O., Tschop M. H., D'Alessio D., and, Desai P. B., (2013) The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects. Eur. J. Endocrinol. 168, 821-828.
46. Waseem T., Duxbury M., Ito H., Ashley S. W., and, Robinson M. K., (2008) Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 143, 334-342.
47. Wortley K. E., Anderson K. D., Garcia K., et al,. (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc. Natl Acad. Sci. USA 101, 8227-8232.
48. Wortley K. E., del Rincon J. P., Murray J. D., Garcia K., Iida K., Thorner M. O., and, Sleeman M. W., (2005) Absence of ghrelin protects against early-onset obesity. J. Clin. Investig. 115, 3573-3578.
49. Wren A. M., Small C. J., Ward H. L., et al,. (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325-4328.
50. Wren A. M., Seal L. J., Cohen M. A., Brynes A. E., Frost G. S., Murphy K. G., Dhillo W. S., Ghatei M. A., and, Bloom S. R., (2001) Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 86, 5992.
51. Yang J., Brown M. S., Liang G., Grishin N. V., and, Goldstein J. L., (2008) Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132, 387-396.
52. You Z., Luo C., Zhang W., Chen Y., He J., Zhao Q., Zuo R., and, Wu Y., (2011) Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression. Behav. Brain Res. 225, 135-141.
53. Zhao T. J., Liang G., Li R. L., et al,. (2010) Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc. Natl Acad. Sci. USA 107, 7467-7472.